
Guidelines blur treatment decisions for PID
Many physicians who treat adolescent girls with pelvic inflammatory disease (PID) are uncertain about choosing hospitalization or outpatient care for their patients by using current guidelines, a new study has found.
Many physicians who treat adolescent girls with pelvic inflammatory disease (PID) are uncertain about choosing hospitalization or outpatient care for their patients by using current guidelines, a new
Centers for Disease Control and Prevention (CDC) guidelines recommend outpatient rather than in-hospital treatment for PID, but leave physicians room for interpretation about treatment choice and outcome from patient to patient. However, data show that adolescent girls with PID often do not follow outpatient treatment regimens and miss follow-up appointments.
Researchers from
Findings showed that ambivalence was common when the clinicians were uncertain about patients’ ability to care for themselves, their willingness to take medications, or their willingness to share diagnoses with partners. Male clinicians and those who were not parents themselves were more likely to hospitalize patients than female clinicians and clinicians with their own children. Many clinicians were uncomfortable with sending a patient home with a complicated treatment regimen, then asking her to return for follow-up, even though the guidelines state that this should be done.
The investigators point out that clinical guidelines should offer clear decision-making algorithms while giving physicians autonomy and flexibility. Lack of clear guidance forces clinicians to make decisions based upon personal bias rather than upon evidence from best practices, they say.
The CDC
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.












